Načítá se...
Benzodiazepine receptor quantification in Huntington's disease with [(123)I]iomazenil and SPECT
OBJECTIVES—Increasing evidence suggests that metabolic changes predate neuronal death in Huntington's disease and emission tomography methods (PET and SPECT) have shown changes in glucose consumption and receptor function in early and possibly even presymptomatic disease. Because the GABA(A)-be...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Group
2001
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1737353/ https://ncbi.nlm.nih.gov/pubmed/11309461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.70.5.657 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|